Literature DB >> 15158762

Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages.

Chinh Quoc Duong1, Salim Maa Bared, Ahmad Abu-Khader, Christa Buechler, Anna Schmitz, Gerd Schmitz.   

Abstract

Some of the biological effects of lipoproteins have been attributed to their association with lysophosphatidic acid (LPA), lysophosphatidylcholine (LPC), sphingosine-1-phosphate (S1P) and sphingosylphosphorylcholine (SPC). These lysophospholipids mediate multiple biological responses via several G protein-coupled receptors (GPR). The expression of these receptors, however, has not been systematically investigated in primary human monocytes and macrophages as major cells involved in atherosclerosis. The mRNAs for all 15 receptors described so far were detected in monocytes, macrophages, foam cells and high density lipoprotein (HDL(3))-treated cells using real time RT-PCR. Immunoblots revealed that S1P(1), S1P(2), S1P(4), LPA(1), LPA(2) and GPR65 are expressed in monocytes and macrophages, while S1P(5) and LPA(3) have not been detected. S1P(3) was induced during differentiation but down-regulated by lipid-loading and HDL(3), whereas LPA(1) was down-regulated in differentiated macrophages. The influence of S1P on macrophages was investigated and the induction of CD32 indicates an enhanced phagocytic activity. Altogether, these data give insights into the expression and regulation of lysophospholipid receptors in primary human monocytes, macrophages and foam cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158762     DOI: 10.1016/j.bbalip.2004.03.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells.

Authors:  Hyoseok Yi; Seong Jin Lee; Jiyeong Lee; Chang-Seon Myung; Woo-Kyu Park; Hee-Jong Lim; Ge Hyeong Lee; Jae Yang Kong; Heeyeong Cho
Journal:  Neurochem Res       Date:  2011-06-15       Impact factor: 3.996

3.  Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

Authors:  Koichi Sato; Fumikazu Okajima
Journal:  World J Biol Chem       Date:  2010-11-26

Review 4.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

Review 5.  The influence of Arhgef1 on pulmonary leukocyte function.

Authors:  Yue Guan; Raul M Torres; John M Hartney
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Antibody Cross-Linking of CD14 Activates MerTK and Promotes Human Macrophage Clearance of Apoptotic Neutrophils: the Dual Role of CD14 at the Crossroads Between M1 and M2c Polarization.

Authors:  Gaetano Zizzo; Philip L Cohen
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

7.  Francisella tularensis LVS induction of prostaglandin biosynthesis by infected macrophages requires specific host phospholipases and lipid phosphatases.

Authors:  Aaron R Navratil; Ashley M Brummett; Joshua D Bryan; Matthew D Woolard
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

8.  Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.

Authors:  Marion David; Irma Machuca-Gayet; Junichi Kikuta; Penelope Ottewell; Fuka Mima; Raphael Leblanc; Edith Bonnelye; Johnny Ribeiro; Ingunn Holen; Rùben Lopez Vales; Pierre Jurdic; Jerold Chun; Philippe Clézardin; Masaru Ishii; Olivier Peyruchaud
Journal:  J Biol Chem       Date:  2014-01-15       Impact factor: 5.157

9.  Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors.

Authors:  Megan M Price; Dmitri Kapitonov; Jeremy Allegood; Sheldon Milstien; Carole A Oskeritzian; Sarah Spiegel
Journal:  FASEB J       Date:  2009-06-17       Impact factor: 5.191

10.  The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment.

Authors:  Qiao Cheng; Shoubao Ma; Dandan Lin; Yu Mei; Huanle Gong; Lei Lei; Yuanyuan Chen; Ye Zhao; Bo Hu; Yan Wu; Xiao Yu; Lixiang Zhao; Haiyan Liu
Journal:  Cell Mol Immunol       Date:  2014-08-04       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.